Literature DB >> 25311346

MSLT-I-response of clinical trial investigators.

James C Yang1, Richard M Sherry1.   

Abstract

Mesh：

Year:  2014        PMID： 25311346     DOI： 10.1038/nrclinonc.2014.65-c2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

1.  Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.

Authors:  U Veronesi; J Adamus; D C Bandiera; I O Brennhovd; E Caceres; N Cascinelli; F Claudio; R L Ikonopisov; V V Javorskj; S Kirov; A Kulakowski; J Lacoub; F Lejeune; Z Mechl; A Morabito; I Rodé; S Sergeev; E van Slooten; K Szcygiel; N N Trapeznikov
Journal:  N Engl J Med       Date:  1977-09-22       Impact factor: 91.245

2.  MSLT-I-response of clinical trial investigators.

Authors:  Mark B Faries; Alistair J Cochran; John F Thompson
Journal:  Nat Rev Clin Oncol       Date:  2014-10-14       Impact factor: 66.675

3.  Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study.

Authors:  F H Sim; W F Taylor; D J Pritchard; E H Soule
Journal:  Mayo Clin Proc       Date:  1986-09       Impact factor: 7.616

4.  Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

Authors:  N Cascinelli; A Morabito; M Santinami; R M MacKie; F Belli
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

5.  Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.

Authors:  C M Balch; S Soong; M I Ross; M M Urist; C P Karakousis; W J Temple; M C Mihm; R L Barnhill; W R Jewell; H J Wanebo; R Harrison
Journal:  Ann Surg Oncol       Date:  2000-03       Impact factor: 5.344

6.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

7.  Melanoma: Why is sentinel lymph node biopsy 'standard of care' for melanoma?

Authors:  James C Yang; Richard M Sherry; Steven A Rosenberg
Journal:  Nat Rev Clin Oncol       Date:  2014-04-15       Impact factor: 66.675
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.